1. Home
  2. ARDX vs RYZ Comparison

ARDX vs RYZ Comparison

Compare ARDX & RYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.09

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Ryerson Holding Corporation Common Stock

RYZ

Ryerson Holding Corporation Common Stock

N/A

Current Price

$30.96

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ARDX
RYZ
Founded
2007
1842
Country
United States
United States
Employees
N/A
4300
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ARDX
RYZ
Price
$5.09
$30.96
Analyst Decision
Strong Buy
Hold
Analyst Count
7
1
Target Price
$15.14
N/A
AVG Volume (30 Days)
3.4M
387.9K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
2.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,000.00
N/A
Revenue This Year
$37.75
$75.79
Revenue Next Year
$34.24
$2.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$19.34
52 Week High
$8.40
$31.45

Technical Indicators

Market Signals
Indicator
ARDX
RYZ
Relative Strength Index (RSI) 38.69 66.97
Support Level $4.95 $23.49
Resistance Level $5.34 N/A
Average True Range (ATR) 0.17 1.13
MACD 0.01 0.36
Stochastic Oscillator 21.12 84.09

Price Performance

Historical Comparison
ARDX
RYZ

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About RYZ Ryerson Holding Corporation Common Stock

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.

Share on Social Networks: